These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 37026249)
1. Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease. Kate A; Shanbhag SS; Donthineni PR; Amescua G; Quinones VLP; Basu S Indian J Ophthalmol; 2023 Apr; 71(4):1176-1189. PubMed ID: 37026249 [TBL] [Abstract][Full Text] [Related]
2. Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults. Edwards Mayhew RG; Li T; McCann P; Leslie L; Strong Caldwell A; Palestine AG Cochrane Database Syst Rev; 2022 Oct; 10(10):CD014831. PubMed ID: 36315029 [TBL] [Abstract][Full Text] [Related]
3. Systemic Immunosuppression in Cornea and Ocular Surface Disorders: A Ready Reckoner for Ophthalmologists. Kate A; Basu S Semin Ophthalmol; 2022 Apr; 37(3):330-344. PubMed ID: 34423717 [TBL] [Abstract][Full Text] [Related]
4. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Cordero-Coma M; Anzaar F; Sobrin L; Foster CS Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834 [TBL] [Abstract][Full Text] [Related]
5. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589 [TBL] [Abstract][Full Text] [Related]
6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine. Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138 [TBL] [Abstract][Full Text] [Related]
7. Current medical treatment of ocular mucous membrane pemphigoid. Sobolewska B; Deuter C; Zierhut M Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229 [TBL] [Abstract][Full Text] [Related]
11. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy for eye diseases: Effectiveness, safety, side effects and their prevention. Hornbeak DM; Thorne JE Taiwan J Ophthalmol; 2015; 5(4):156-163. PubMed ID: 29018691 [TBL] [Abstract][Full Text] [Related]
13. Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality. Kempen JH; Newcomb CW; Washington TL; Foster CS; Sobrin L; Thorne JE; Jabs DA; Suhler EB; Rosenbaum JT; Sen HN; Levy-Clarke GA; Nussenblatt RB; Bhatt NP; Lowder CY; Goldstein DA; Leiderman YI; Acharya NR; Holland GN; Read RW; Dunn JP; Dreger KA; Artornsombudh P; Begum HA; Fitzgerald TD; Kothari S; Payal AR; Daniel E; Gangaputra SS; Kaçmaz RO; Liesegang TL; Pujari SS; Khachatryan N; Maghsoudlou A; Suga HK; Pak CM; Helzlsouer KJ; Buchanich JM; Ophthalmology; 2023 Dec; 130(12):1258-1268. PubMed ID: 37499954 [TBL] [Abstract][Full Text] [Related]
14. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Larkins NG; Liu ID; Willis NS; Craig JC; Hodson EM Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002290. PubMed ID: 32297308 [TBL] [Abstract][Full Text] [Related]
15. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Wilson SE; Perry HD Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588 [TBL] [Abstract][Full Text] [Related]
16. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease. Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863 [TBL] [Abstract][Full Text] [Related]
17. [Mucous membrane pemphigoid with ocular involvement. Part II: therapy]. Meyer-ter-Vehn T; Schmidt E; Zillikens D; Geerling G Ophthalmologe; 2008 Apr; 105(4):405-19. PubMed ID: 18392628 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102 [TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Kiss S; Ahmed M; Letko E; Foster CS Ophthalmology; 2005 Jun; 112(6):1066-71. PubMed ID: 15936442 [TBL] [Abstract][Full Text] [Related]